NEW TB VACCINES NEEDED TO TACKLE AMR

  08 March 2023

In a new brief, the TB Vaccine Advocacy Roadmap (TB Vax ARM) coalition draws on the latest research in health and economic modelling to demonstrate how new TB vaccines could significantly help control drug-resistant TB, in a cost-effective and affordable way. This brief shares a collective call to decision-makers to prioritize TB vaccine research and development (R&D) as a signature piece of global health and AMR agendas. TB vaccines remain neglected in the AMR agenda despite the World Health Organization calling for the highest priority action on TB vaccine development to prevent AMR.

Download the brief

Further reading: Stop TB Partnership
Author(s): Stop TB Partnership
Effective Surveillance   Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 650 AMR professionals and students in 65 countries!

Register

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed